Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01847040 · ClinicalTrials.gov registry record
Deployment Related Mild Traumatic Brain Injury (mTBI)
A clinical trial of Mild Traumatic Brain Injury, sponsored by The Defense and Veterans Brain Injury Center.
- Completed
- Registry status
- 750
- Enrollment target
- 2
- Study locations
NCT01847040 is a study of Mild Traumatic Brain Injury that has completed, run by The Defense and Veterans Brain Injury Center. The registered enrollment target is 750 participants, above the 203-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (269% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT01847040, a study of Mild Traumatic Brain Injury, has completed, sponsored by The Defense and Veterans Brain Injury Center.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will provide evidence on the long term outcomes of mTBI in service members returning from Afghanistan and Iraq. In addition, the study will provide evidence on mTBI incidence, and symptom patterns. Self-reported assessments at baseline and follow-ups will be combined with data on health care utilization and military job performance. The work, symptoms, and family interaction outcomes of returning soldiers screening positive for mTBI, combined mTBI and PTSD, and soldier controls will be compared at 3 months, 6 months, and at one year. The assessments over time will permit descriptions of symptom changes for these populations. It is likely the study will find similar findings to those of previous civilian studies - that concussive symptoms often resolve within months of injury. However, some soldier subsets may have chronic problems. Determining the incidence and outcomes of individuals with mTBI will assist medical providers in determining the types of follow-ups needed by returning service members and suggest the development of additional treatment interventions. These results may also inform treatment of civilian populations with mTBI. The three primary hypotheses are: 1. Concussive symptoms at the time of return from serving in Afghanistan and Iraq and symptoms persisting 3 months, 6 months, and 12 months after return will be associated with extent of exposure to combat, injury mechanism, associated injuries (co-occuring injuries), PTSD and other psychiatric co-morbidities, and number of deployment-related mTBIs. 2. Returning troops reporting concussive symptoms at the time of return from deployment will have more work related problems at each follow-up (including lower rates of return to duty, return to work, and poor quality of work). 3. The mTBI screening tool will be sensitive and specific to mTBI when compared to the criterion measure, which is a structured interview conducted by clinicians blinded to the screening results.
Conditions Studied
Study Locations (2)
Colorado
- Fort Carson - Fort Carson
North Carolina
- Fort Bragg - Fort Bragg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2009-09 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01847040
The ClinicalTrials.gov registry entry for NCT01847040 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 203-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (269% higher). The listed sponsor is The Defense and Veterans Brain Injury Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 0 interventions.
NCT01847040 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01847040 about?
NCT01847040 is a clinical study titled "Deployment Related Mild Traumatic Brain Injury (mTBI)". The study will provide evidence on the long term outcomes of mTBI in service members returning from Afghanistan and Iraq. In addition, the study will provide evidence on mTBI incidence, and symptom patterns. Self-reported assessments at baseline and follow-ups will be combined with data on health ca...
What is the current status of trial NCT01847040?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2009-09. Estimated completion is 2014-08.
What conditions does trial NCT01847040 study?
This clinical trial studies the following conditions: Mild Traumatic Brain Injury.
Who is sponsoring clinical trial NCT01847040?
This trial is sponsored by The Defense and Veterans Brain Injury Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01847040 being conducted?
This trial has 2 study locations across Colorado, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Concussion Recovery and Support Program
RECRUITING · NA
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Personalized Brain Stimulation to Treat Chronic Concussive Symptoms
RECRUITING · Phase 2
-
Risk Stratification in Children With Concussion
RECRUITING
-
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
RECRUITING · NA
-
Passive Neurosensory Reintegration Training as a Tool to Augment Mild Traumatic Brain Injury
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.